Prediction, progression and prevention of diabetic nephropathy. The Minkowski Lecture 2005.
about
Why do some patients with type 1 diabetes live so long?Diabetic kidney disease: a report from an ADA Consensus ConferenceImprovements in the Management of Diabetic NephropathyFunctional annotations of diabetes nephropathy susceptibility loci through analysis of genome-wide renal gene expression in rat models of diabetes mellitus.Cardiovascular disease biomarkers are associated with declining renal function in type 2 diabetes.The relationship of retinal vessel diameter to changes in diabetic nephropathy structural variables in patients with type 1 diabetes.The effects of GLP-1 analogues, DPP-4 inhibitors and SGLT2 inhibitors on the renal system.Diagnosis and Prediction of CKD Progression by Assessment of Urinary PeptidesHLA-DRB1*03 as a risk factor for microalbuminuria in same duration of type 1 diabetes: a case control studyComparison of different blood pressure indices for the prediction of prevalent diabetic nephropathy in a sub-Saharan African population with type 2 diabetes.Inflammatory cytokines as predictive markers for early detection and progression of diabetic nephropathyUrinary proteomics for early diagnosis in diabetic nephropathy.Comprehensive approach to diabetic nephropathy.Proteomic prediction and Renin angiotensin aldosterone system Inhibition prevention Of early diabetic nephRopathy in TYpe 2 diabetic patients with normoalbuminuria (PRIORITY): essential study design and rationale of a randomised clinical multicentreIncreased risk of CKD among type 2 diabetics with nonalcoholic fatty liver diseaseMicrovascular disease in children and adolescents with type 1 diabetes and obesity.Reno-protective mechanisms of epoxyeicosatrienoic acids in cardiovascular disease.Association of serum uric acid levels with the risk of development or progression of albuminuria among Japanese patients with type 2 diabetes: a prospective cohort study [Diabetes Distress and Care Registry at Tenri (DDCRT 10)].Future strategies to prevent renal microvascular disease complications in diabetes.Earlier intensified insulin treatment of Type 1 diabetes and its association with long-term macrovascular and renal complications.Role of haem oxygenase in the renoprotective effects of soluble epoxide hydrolase inhibition in diabetic spontaneously hypertensive rats.Diabetic nephropathy: Could problems with bardoxolone methyl have been predicted?Hepatic steatosis and non-alcoholic fatty liver disease are not associated with decline in renal function in people with Type 2 diabetes.Proteome Profiling of Diabetic Mellitus Patient Urine for Discovery of Biomarkers by Comprehensive MS-Based Proteomics.Elevated urinary N-acetyl-β-D-glucosaminidase is associated with high glycoalbumin-to-hemoglobin A1c ratio in type 1 diabetes patients with early diabetic kidney disease.How to get proteomics to the clinic? Issues in clinical proteomics, exemplified by CE-MSThe possible role of esRAGE and sRAGE in the natural history of diabetic nephropathy in childhood
P2860
Q26858877-2CADA3E5-201C-48EE-8BAA-91A4201CE7DBQ27012546-CF9DDCD6-9B75-43A0-A2DF-D0478D03F830Q28080717-6DD99500-E364-40EB-B0D2-ADE48955031FQ33479791-4A59B027-9DC8-40DD-A8B4-D74AA4C35339Q33854492-06D0DB21-49E6-4BDF-8524-E6EAB01A4B41Q33942688-65B27D9B-B82D-4C5E-A18A-FB04E893DE43Q34503796-C231431F-D5EE-40A2-8486-8CC945BED714Q35903097-BD4D032F-309D-4E54-84F7-2C5F1014A707Q35976961-742C8A90-52CB-4545-A9F2-948631084915Q35990916-1BB1D711-B701-447B-8D7A-13E806CC14E3Q36117573-D73204A7-D861-4ED0-99D6-ECF7A2B9DAF1Q36410737-E572BD98-A798-44CB-B775-CE36D3163FEAQ36466019-AC204F48-827D-486C-A144-E8500AF99567Q36670632-D9FC09FC-AA81-4B04-9F9F-5FF5CFC9D581Q36796750-8C68A810-D947-41DE-823F-90DAACDB006AQ37780987-B7D2721D-4AB0-4213-8E27-9B5DDDC7FF2CQ37960812-17FCD939-A00B-4502-B4FC-7DE01603DA69Q38900912-6CBC6D3E-56EB-4839-8035-9CB80C23C0C7Q40139541-CAAC6572-ABCE-42FD-9354-634610EEB6EFQ40599056-BD7B72D3-5EB9-44AB-9F59-7FAA99E40A8CQ42711742-B74DDF4D-6FC4-4939-BF1C-4C3D963831B5Q43679311-792DF241-B06B-4BCE-B90E-B20C44840382Q44682506-87846C3C-5240-4F9B-806E-4103C0CA1DD5Q50131991-EA1E9A19-ADC0-4E44-9E28-6BA863497C57Q55340247-9014DDC3-E8EB-4BEC-A834-678D0EE3A315Q57711927-35E27B2D-5F31-4C83-BD4B-35BFE7E03BEEQ57718003-FFCE715F-3035-40D3-A503-9D292803F47C
P2860
Prediction, progression and prevention of diabetic nephropathy. The Minkowski Lecture 2005.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Prediction, progression and pr ...... y. The Minkowski Lecture 2005.
@en
Prediction, progression and pr ...... y. The Minkowski Lecture 2005.
@nl
type
label
Prediction, progression and pr ...... y. The Minkowski Lecture 2005.
@en
Prediction, progression and pr ...... y. The Minkowski Lecture 2005.
@nl
prefLabel
Prediction, progression and pr ...... y. The Minkowski Lecture 2005.
@en
Prediction, progression and pr ...... y. The Minkowski Lecture 2005.
@nl
P2860
P1433
P1476
Prediction, progression and pr ...... y. The Minkowski Lecture 2005.
@en
P2093
P2860
P2888
P356
10.1007/S00125-005-0077-3
P577
2005-12-09T00:00:00Z